Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Clinical trial NCT04770922 · COMPLETED

Trial details

NCT number: NCT04770922
Sponsor: Cipherome, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia, Pediatric Adverse Drug Event

Start date: 2021-02-23
Primary completion: 2021-08-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.